PT Semen Indonesia (Persero) Tbk (PSGTF) Stock Price & Analysis
PT Semen Indonesia (Persero) Tbk (PSGTF) — price $0.07 (0.00%), as of the Nov 19, 2026 trading session; market cap $471M.
Educational signal · not a buy or sell recommendation · How to read this
PT Semen Indonesia (Persero) Tbk · PSGTF
PT Semen Indonesia (Persero) Tbk is Indonesia's largest cement producer, with operations spanning manufacturing, distribution, and related services. The company faces challenges and opportunities in a dynamic construction materials market.
Price as of Nov 19, 2026
Key Statistics
Not scored: MoonshotScore covers actively traded US operating companies, not funds, preferred shares, warrants or thinly traded stocks.
Thousands of the 20,000+ US stocks here carry a MoonshotScore.
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $0.07 | |
| Change on the day | 0.00% | |
| Market capitalisation | $471M | — |
| Price / earnings (trailing) | 18.40 | |
| Shares traded on the day | 2.5K |
Price & events
Other perspectives
Council score for PT Semen Indonesia (Persero) Tbk (PSGTF): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Legends Council
4 lenses, 4 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Nov 19, 2026
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Sep 10, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Sep 10, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.
Readings on this page are from Nov 20, 2026, except a card that shows its own read date.
What is PT Semen Indonesia (Persero) Tbk (PSGTF), and what does it report?
Short answer
A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. PT Semen Indonesia (Persero) Tbk (PSGTF) is the company analyzed here. It employs 8,496 people. In Q3 FY2026 it reported revenue of IDR 10003.66B and net income of IDR 303.12B. The market values it at $471M.
What do the latest results show for PT Semen Indonesia (Persero) Tbk (PSGTF)?
Short answer · as of
The most recent reported quarter, Q3 FY2026, carried revenue of IDR 10003.66B. Against analyst estimates the company has EPS beat 3 of the last 8 reports.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q3 FY2026 | IDR 10003.66B | IDR 303.12B | IDR 44.58 (diluted) |
| Q2 FY2026 | IDR 9218.89B | IDR 145.67B | IDR 21.10 (diluted) |
| Q1 FY2026 | IDR 8307.48B | IDR 80.53B | IDR 12.00 (diluted) |
| Q4 FY2025 | IDR 9989.51B | IDR 76.40B | IDR 11.34 (diluted) |
What are the financial strengths and risks for PT Semen Indonesia (Persero) Tbk (PSGTF)?
Short answer · as of
The distress and quality screens read Altman Z 1.47 · Piotroski F 7. Trailing ratios: ROE 1.4% · ROA 0.8% · current ratio 1.10 · earnings yield 6.4% · free-cash-flow yield 38.6%.
Data-derived red flags
- Financial-distress signal — its Altman Z-Score of 1.47 sits in the distress zone (elevated bankruptcy risk).
- Inconsistent delivery — missed Wall Street EPS estimates in 4 of the last 8 reported quarters.
The records behind this page
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held PSGTF in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported PSGTF in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
Common Questions About PSGTF
These answers are editorial: 1 of these 8 answers is drawn from the PSGTF research dossier (written Mar 16, 2026 by gemini-2.0-flash); the other 7 are question templates that restate figures shown above. Figures in this section are not part of the source register.
Is PSGTF a good stock to buy?
Stock Expert AI does not rate PSGTF buy, sell or hold. PT Semen Indonesia (Persero) Tbk has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.
What is the PSGTF stock price today?
The last price recorded for PT Semen Indonesia (Persero) Tbk (PSGTF), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What are the main risks for PSGTF?
The main risks for PT Semen Indonesia (Persero) Tbk include intense competition from both domestic and international cement producers, which could pressure prices and reduce market share. Fluctuations in raw material costs, such as limestone and energy, can impact profitability. Economic slowdowns in Indonesia or key export markets could decrease demand for cement.
What are the key factors to evaluate for PSGTF?
Evaluate PSGTF on fundamentals, analyst consensus, and risk factors. To weigh it, start with the trailing P/E under Price & valuation on this page. Expansion in Infrastructure Projects: The Indonesian government's focus on infrastructure development presents a significant growth opportunity. Not financial advice.
How frequently does PSGTF data refresh on this page?
PSGTF's price is the last quote we recorded, from the Nov 19, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.
What has driven PSGTF's recent stock price performance?
PT Semen Indonesia (Persero) Tbk (PSGTF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Leading market share in Indonesia. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider PSGTF overvalued or undervalued right now?
The trailing P/E of PT Semen Indonesia (Persero) Tbk (PSGTF) is listed under Price & valuation on this page. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research PSGTF before investing?
Before investing in PT Semen Indonesia (Persero) Tbk (PSGTF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 16, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 13 figures on this page — 9 from Financial Modeling Prep (FMP) and 4 with no recorded source. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com